Crewe Advisors’s LifeMD LFMD Stock Holding History

Crewe Advisors’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-300	Closed	-$1.57K	–	739
2024 Q3	$1.57K	Hold	300	–	–	﹤0.01%	628
2024 Q2	$2.06K	Buy	+300	New	+$2.75K	﹤0.01%	869

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Crewe Advisors's LFMD Position: Q4 2024 in Review

Crewe Advisors sold out of LifeMD (LFMD) in Q4 2024, closing a stake of 300 shares — an estimated $1.57K sold.

Crewe Advisors first reported a position in LFMD in Q2 2024 and held it in 2 quarters. The position peaked at $2.06K in Q2 2024. 106 funds tracked by Wall St. Rank hold LFMD as of Q4 2024.

Crewe Advisors reported no remaining LifeMD position as of Q4 2024 after selling out during the quarter.
Crewe Advisors sold 300 LifeMD shares in Q4 2024, an estimated $1.57K.
Crewe Advisors first reported a position in LifeMD in Q2 2024 and held it in 2 quarters.
Crewe Advisors's LifeMD position peaked at $2.06K in Q2 2024.
106 funds tracked by Wall St. Rank held LifeMD as of Q4 2024.

Based on Crewe Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.